Biomatics Capital
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Portal
Select Page

Cytrellis

Medical Technology
Developing a new class of aesthetic devices
https://www.cytrellis.com

Press Releases

Cytrellis Biosystems Completes $28.5 Million Series B Financing

Jun 5, 2018

Merz Pharma announces new investment in Cytrellis Biosystems

Apr 27, 2016

Press Coverage

Novel Dermal Microcoring Device Holds Promise for Moderate to Severe Wrinkles

Sep 11, 2019

Dermatology News: Novel dermal coring device effective for facial rejuvenation without using thermal energy

Jun 24, 2019

© Copyright 2025 Biomatics Capital